Azaphilones inhibit tau aggregation and dissolve tau aggregates in vitro

View/ Open
Issue Date
2015-04-15Author
Paranjape, Smita Ramesh
Riley, Andrew Philip
Somoza, Amber D.
Oakley, C. Elizabeth
Wang, Clay C. C.
Prisinzano, Thomas E.
Oakley, Berl R.
Gamblin, Truman Chris
Publisher
ACS
Type
Article
Article Version
Scholarly/refereed, author accepted manuscript
Rights
Copyright © 2015 American Chemical Society
Metadata
Show full item recordAbstract
The aggregation of the microtubule-associated protein tau is a seminal event in many neurodegenerative diseases, including Alzheimer’s disease. The inhibition or reversal of tau aggregation is therefore a potential therapeutic strategy for these diseases. Fungal natural products have proven to be a rich source of useful compounds having wide varieties of biological activities. We have previously screened Aspergillus nidulans secondary metabolites for their ability to inhibit tau aggregation in vitro using an arachidonic acid polymerization protocol. One aggregation inhibitor identified was asperbenzaldehyde, an intermediate in azaphilone biosynthesis. We therefore tested 11 azaphilone derivatives to determine their tau assembly inhibition properties in vitro. All compounds tested inhibited tau filament assembly to some extent, while four of the 11 compounds had the advantageous property of disassembling preformed tau aggregates in a dose-dependent fashion. The addition of these compounds to the tau aggregates reduced both the total length and numbers of tau polymers. The most potent compounds were tested in in vitro reactions to determine whether they interfere with tau’s normal function of stabilizing microtubules (MTs). We found that they did not completely inhibit MT assembly in the presence of tau. These derivatives are very promising lead compounds for tau aggregation inhibitors and, more excitingly, for compounds that can disassemble pre-existing tau filaments. They also represent a new class of anti-tau aggregation compounds with a novel structural scaffold.
Collections
Citation
Paranjape, S. R., Riley, A. P., Somoza, A. D., Oakley, C. E., Wang, C. C. C., Prisinzano, T. E., … Gamblin, T. C. (2015). Azaphilones inhibit tau aggregation and dissolve tau aggregates in vitro. ACS Chemical Neuroscience, 6(5), 751–760. http://doi.org/10.1021/acschemneuro.5b00013
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.